Boundless Bio Appoints New CMO, Elects Director
Ticker: BOLD · Form: 8-K · Filed: Aug 20, 2024 · CIK: 1782303
| Field | Detail |
|---|---|
| Company | Boundless Bio, INC. (BOLD) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $3.71, $3.56, $4.10, $16.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, board-election, compensation
TL;DR
Boundless Bio brings in a new CMO and adds a director to the board.
AI Summary
Boundless Bio, Inc. announced on August 19, 2024, the appointment of Dr. David M. Halbert as Chief Medical Officer and the election of Ms. Sarah E. Kelly to its Board of Directors. The company also disclosed compensatory arrangements for certain officers, details of which are filed as an exhibit.
Why It Matters
These executive and board changes can signal shifts in the company's strategic direction and leadership, potentially impacting its future development and operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Boundless Bio, Inc. (company) — Registrant
- Dr. David M. Halbert (person) — Appointed Chief Medical Officer
- Ms. Sarah E. Kelly (person) — Elected to Board of Directors
- August 19, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer of Boundless Bio?
Dr. David M. Halbert has been appointed as the new Chief Medical Officer of Boundless Bio.
Who has been elected to the Board of Directors of Boundless Bio?
Ms. Sarah E. Kelly has been elected to the Board of Directors of Boundless Bio.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is August 19, 2024.
What is the principal executive office address for Boundless Bio?
The address of the Principal Executive Offices is 9880 Campus Point Drive, Suite 120, San Diego, California 92121.
What other information is Boundless Bio filing regarding its officers?
Boundless Bio is filing information regarding compensatory arrangements of certain officers.
Filing Stats: 751 words · 3 min read · ~3 pages · Grade level 12 · Accepted 2024-08-20 17:00:22
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share BOLD Nasdaq Global Select
- $3.71 — ion with an exercise price per share of $3.71 or greater held by those employees elig
- $3.56 — igible for the Repricing was reduced to $3.56 per share, the closing price of our com
- $4.10 — h original exercise prices ranging from $4.10 to $16.00; Klaus Wagner, M.D., Ph.D., C
- $16.00 — l exercise prices ranging from $4.10 to $16.00; Klaus Wagner, M.D., Ph.D., Chief Medic
Filing Documents
- bold-20240819.htm (8-K) — 37KB
- 0000950170-24-099185.txt ( ) — 149KB
- bold-20240819.xsd (EX-101.SCH) — 24KB
- bold-20240819_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BOUNDLESS BIO, INC. Date: August 20, 2024 By: /s/ Jessica Oien Name: Jessica Oien Title: Chief Legal Officer and Corporate Secretary